Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F3 | P13726 | 17/20 | 0.49 |
| ▸ | F7 | P08709 | 15/20 | 0.49 |
| ▸ | F10 | P00742 | 13/20 | 0.49 |
| ▸ | F2 | P00734 | 12/20 | 0.49 |
| ▸ | PLG | P00747 | 7/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSS | P25774 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7651357 | 0.92 | F3 (0.47) | F3F7F10F2PLG | |
| SCHEMBL7663442 | 0.88 | F3 (0.46) | F3F7F10F2PLG | |
| SCHEMBL7665681 | 0.88 | HSP90AA1 (0.44) | F7F10F2PRSS1HSP90AA1 | |
| SCHEMBL7651288 | 0.86 | F3 (0.48) | F3F7F10F2PLG | |
| SCHEMBL7656373 | 0.81 | F7 (0.42) | F3F7F10F2PLG | |
| SCHEMBL7658729 | 0.79 | F7 (0.76) | F3F7F10F2PLG | |
| SCHEMBL7661958 | 0.79 | F7 (0.79) | F3F7F10F2PLG | |
| SCHEMBL7656586 | 0.77 | HSP90AA1 (0.48) | HSP90AA1CA1CA2 | |
| SCHEMBL7655865 | 0.77 | HSP90AA1 (0.47) | F7F10F2PRSS1HSP90AA1 | |
| SCHEMBL7656851 | 0.77 | F7 (0.72) | F3F7F10F2PLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6358960-B1 | FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-03-19 | — | — | US | disclosed |
| EP-1078917-A1 | AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-02-28 | — | — | EP | disclosed |